BLINQ PRO Trademark

Trademark Overview

On Thursday, February 6, 2020, a trademark application was filed for BLINQ PRO with the United States Patent and Trademark Office. The USPTO has given the BLINQ PRO trademark a serial number of 88787120. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Rebiscan, Inc.. The BLINQ PRO trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments for use in assessing amblyopia
blinq pro

General Information

Serial Number88787120
Word MarkBLINQ PRO
Filing DateThursday, February 6, 2020
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6357096
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements

Goods and ServicesMedical instruments for use in assessing amblyopia

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 10, 2020
Primary Code010
First Use Anywhere DateFriday, October 25, 2019
First Use In Commerce DateFriday, June 19, 2020

Trademark Owner History

Party NameRebiscan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02114
Party NameRebiscan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02114
Party NameRebiscan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02114

Trademark Events

Event DateEvent Description
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 13, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 24, 2021ASSIGNED TO LIE
Monday, March 15, 2021ASSIGNED TO LIE
Friday, December 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 4, 2020NON-FINAL ACTION E-MAILED
Friday, December 4, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, November 12, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 27, 2020USE AMENDMENT FILED
Tuesday, November 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 27, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, October 27, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 30, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, July 30, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 30, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, July 30, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 27, 2020NON-FINAL ACTION E-MAILED
Monday, April 27, 2020NON-FINAL ACTION WRITTEN
Monday, April 27, 2020ASSIGNED TO EXAMINER
Monday, February 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 10, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

blinq amblyopia assessing instruments medical